The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy.
Hepatol Int
; 17(6): 1519-1531, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37707759
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Sarcopenia
/
Liver Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Hepatol Int
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Estados Unidos